Search

everythinglearnresearchcommunity

for

Search:↓

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Tocilizumab might be an effective treatment for COVID-19.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Some drugs may help treat both COVID-19 and radiation injury.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Social media can help compare the effectiveness and safety of new arthritis medications.

New treatments for lupus show promise, but more research is needed, especially for children.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Immune cells affect hair growth and could lead to new hair loss treatments.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.